Antihistamine Market Size (2024 - 2029)

Antihistamine Market Analysis

The Antihistamine Market is expected to register a CAGR of 7.70% during the forecast period.

The market’s growth is driven by factors like rising allergies and stomach disorders issues and increasing research and development activities for novel dosage forms. The rising burden of allergies and acid reflex are anticipated to drive the market's growth during the forecast period. For instance, according to the data published by the Asthma and Allergy Foundation of America in April 2024, nearly one-third of American adults and over a quarter of American children suffer from seasonal allergies, eczema, or food allergies each year.

According to a study published in Rawal Medical Journal in September 2022, the prevalence of gastroesophageal reflux disease (GERD) was found to be 18.1% to 27.8% in North America, 8.8% to 25.9% in Europe, 2.5% to 7.8% in East Asia, 8.7% to 33.1% in the Middle East, 11.6% in Australia, and 23% in South America. Therefore, such a massive prevalence of allergies and stomach disorders is anticipated to increase the demand for antihistamines, driving market growth.

Furthermore, companies’ strategic activities, such as collaborations and agreements in using antihistamine medications, are anticipated to bolster market growth during the forecast period. For instance, in March 2023, Astepro Allergy partnered with Meghann Fahy to help patients suffering from allergies. Astepro is a long-lasting nasal spray that starts working in 30 minutes and can relieve allergy symptoms quickly. Therefore, such partnerships increase the usage of antihistamines, which is anticipated to increase their adoption among people and drive market growth.

Therefore, the rising issues of allergies and stomach disorders and the company's strategic activities are anticipated to drive market growth. However, the patent expiry of branded drugs, the introduction of generic drugs, and the adverse effects associated with antihistamine drugs are impeding market growth.

Antihistamine Industry Segmentation

As per the report's scope, antihistamines, a common medication class, are primarily employed to alleviate allergy symptoms. They combat conditions triggered by the body's overproduction of histamine, an immune system byproduct. Predominantly, antihistamines cater to individuals grappling with allergic responses to pollen and other allergens. Beyond allergies, they find utility in managing a spectrum of conditions, spanning from anxiety and colds to gastrointestinal maladies.

The antihistamine market is segmented by drug class, dosage form, type, disease, distribution channels, and geography. By drug class, the market is segmented into H1 antihistamines, H2 antihistamines, and H3 antihistamines. The H1 antihistamines segment is sub-segmented into first-generation and second-generation. By dosage form, the market is segmented into oral route, parenteral route, and other dosage forms. By type, the market is segmented into OTC and prescription-based. By disease, the market is segmented into allergic disorders, stomach disorders, central nervous system disorders, and other diseases. By distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD) for the above segments.